Debco Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 28-12-2024
- Paid Up Capital ₹ 0.10 M
as on 28-12-2024
- Company Age 12 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.20 M
as on 28-12-2024
- Revenue 27.26%
(FY 2022)
- Profit 78.92%
(FY 2022)
- Ebitda 536.82%
(FY 2022)
- Net Worth 27.10%
(FY 2022)
- Total Assets 16.42%
(FY 2022)
About Debco Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹9.20 M.
Chhanda Banerjee, Gaurav Banerjee, and Dwijen Banerjee serve as directors at the Company.
- CIN/LLPIN
U51909WB2012PTC173135
- Company No.
173135
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Jan 2012
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Debco Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gaurav Banerjee  | Managing Director | 30-Jan-2012 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Chhanda Banerjee | Whole-Time Director | 30-Jan-2012 | Current |
| Dwijen Banerjee | Whole-Time Director | 30-Jan-2012 | Current |
Financial Performance of Debco Pharma.
Debco Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 27.26% increase. The company also saw a substantial improvement in profitability, with a 78.92% increase in profit. The company's net worth Soared by an impressive increase of 27.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Debco Pharma?
In 2018, Debco Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 11 Jan 2017 | ₹0.60 M | Open |
Others Creation Date: 07 Sep 2012 | ₹8.60 M | Open |
How Many Employees Work at Debco Pharma?
Unlock and access historical data on people associated with Debco Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Debco Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Debco Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
